iFuse Implant System

About SI-BONE

SI-BONE is a leader in developing and commercializing minimally invasive solutions for sacroiliac joint dysfunction, a condition implicated in 15-30% of chronic low back pain cases. Founded in 2009, the company has established a robust clinical foundation for its iFuse Implant System, including multiple randomized controlled trials and over a hundred peer-reviewed publications. As a publicly traded entity, SI-BONE continues to invest in clinical research and expand its product portfolio to solidify its market position and address adjacent indications like pelvic trauma and spinopelvic fixation.

Therapeutic Areas